Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1/2a Study Evaluating the Safety and Efficacy of RMP-A03 Ocular Suspension in Healthy Volunteers and Patients With Pterygium

NCT05794204 is registered in ClinicalTrials.gov with Suzhou Raymon Pharmaceuticals Company, Ltd. as lead sponsor.

NCT NCT05794204
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05794204 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1/2a Study Evaluating the Safety and Efficacy of RMP-A03 Ocular Suspension in Healthy Volunteers and Patients With Pterygium
Lead sponsor
Suzhou Raymon Pharmaceuticals Company, Ltd.
Phase
Phase 2
Overall status
Completed
Start date
June 9, 2023
Completion date
January 12, 2024
Enrollment
77 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

pterygium